Fulcrum Therapeutics Insider Trades

FULC

Track insider trading activity from Fulcrum Therapeutics executives and directors. See which insiders are buying and selling FULC stock.

Trades Last 12 Months

FULC Price

All Insider Trades for Fulcrum Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ezekowitz Alan Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Geraghty James A Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Banks Sonja Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
King Rachel K. Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Hill Colin Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Haviland Kate Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Dorton Katina Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Gould Robert J Director
Holding Value $115k 32,000 shares
Last Trade
Jun 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 32,000 shares
$3.66
$3.59
Sapir Alex See Remarks
Holding Value $2.33M 650,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.97M 650,000 shares
$10.72
$3.59
Tourangeau Greg Principal Accounting Officer
Holding Value $205k 57,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$611k 57,000 shares
$10.72
$3.59
Musso Alan A Chief Financial Officer
Holding Value $610k 170,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.82M 170,000 shares
$10.72
$3.59
Oltmans Curtis Gale Chief Legal Officer
Holding Value $610k 170,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.82M 170,000 shares
$10.72
$3.59
Holding Value $21.7M 6,053,960 shares
Last Trade
Dec 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$816k 91,722 shares
$8.90
$3.59
Geraghty James A Director
Holding Value $129k 36,000 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266k 36,000 shares
$7.38
$3.59
Collins James J. Director
Holding Value $108k 30,000 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 30,000 shares
$7.00
$3.59
Hayes Melvin H. Iii Chief Operating Officer
Holding Value $413k 115,000 shares
Last Trade
Apr 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 115,000 shares
$2.58
$3.59
Rajavelu Esther Chief Financial Officer
Holding Value $574k 160,000 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.01M 160,000 shares
$12.59
$3.59
Holding Value $7.04M 1,962,202 shares
Last Trade
Dec 13, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$11.7M 2,000,000 shares
$5.85
$3.59
Arroyo Santiago Chief Medical Officer
Holding Value $1.44M 400,000 shares
Last Trade
Nov 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.24M 400,000 shares
$5.61
$3.59
Morabito Christopher Chief Medical Officer
Holding Value $214k 59,744 shares
Last Trade
Jan 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$758k 59,744 shares
$12.69
$3.59

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up